Do Serum Galectin-9 Levels in Women with Gestational Diabetes and Healthy Ones Differ before or after Delivery? A Pilot Study

Gestational diabetes mellitus (GDM) is a common metabolic disease that occurs during pregnancy, with the placenta playing an important role in its pathophysiology. Currently, the role of galectin-9 in the development of GDM is unknown. The aim of this study was to compare galectin-9 concentrations i...

Full description

Bibliographic Details
Main Authors: Aleksandra Pełech, Monika Ruszała, Magdalena Niebrzydowska-Tatus, Katarzyna Bień, Żaneta Kimber-Trojnar, Monika Czuba, Małgorzata Świstowska, Bożena Leszczyńska-Gorzelak
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/13/4/697
_version_ 1797606234364313600
author Aleksandra Pełech
Monika Ruszała
Magdalena Niebrzydowska-Tatus
Katarzyna Bień
Żaneta Kimber-Trojnar
Monika Czuba
Małgorzata Świstowska
Bożena Leszczyńska-Gorzelak
author_facet Aleksandra Pełech
Monika Ruszała
Magdalena Niebrzydowska-Tatus
Katarzyna Bień
Żaneta Kimber-Trojnar
Monika Czuba
Małgorzata Świstowska
Bożena Leszczyńska-Gorzelak
author_sort Aleksandra Pełech
collection DOAJ
description Gestational diabetes mellitus (GDM) is a common metabolic disease that occurs during pregnancy, with the placenta playing an important role in its pathophysiology. Currently, the role of galectin-9 in the development of GDM is unknown. The aim of this study was to compare galectin-9 concentrations in healthy pregnant women and those with GDM. Galectin-9 levels were assessed in serum samples taken both just before and after delivery, as well as in urine samples collected in the postpartum period. Maternal body composition and hydration status were evaluated using the bioelectrical impedance analysis (BIA) method. There were no statistically significant differences in the concentration of galectin-9 in women with GDM compared to healthy pregnant women in their serum samples taken just before delivery, nor in their serum and urine samples collected in the early postpartum period. However, serum galectin-9 concentrations taken before delivery were positively correlated with BMI and parameters related to the amount of adipose tissue assessed in the early postpartum period. Additionally, there was a correlation between serum galectin-9 concentrations taken before and after delivery. Galectin-9 is unlikely to become a diagnostic marker for GDM. However, this subject requires further clinical research in larger groups.
first_indexed 2024-03-11T05:12:18Z
format Article
id doaj.art-b7c70f9c34644dd49e941f62fdf1a99a
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-11T05:12:18Z
publishDate 2023-04-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-b7c70f9c34644dd49e941f62fdf1a99a2023-11-17T18:30:04ZengMDPI AGBiomolecules2218-273X2023-04-0113469710.3390/biom13040697Do Serum Galectin-9 Levels in Women with Gestational Diabetes and Healthy Ones Differ before or after Delivery? A Pilot StudyAleksandra Pełech0Monika Ruszała1Magdalena Niebrzydowska-Tatus2Katarzyna Bień3Żaneta Kimber-Trojnar4Monika Czuba5Małgorzata Świstowska6Bożena Leszczyńska-Gorzelak7Department of Obstetrics and Perinatology, Medical University of Lublin, 20-090 Lublin, PolandDepartment of Obstetrics and Perinatology, Medical University of Lublin, 20-090 Lublin, PolandDepartment of Obstetrics and Perinatology, Medical University of Lublin, 20-090 Lublin, PolandDepartment of Obstetrics and Perinatology, Medical University of Lublin, 20-090 Lublin, PolandDepartment of Obstetrics and Perinatology, Medical University of Lublin, 20-090 Lublin, PolandDepartment of Clinical Genetics, Medical University of Lublin, 20-080 Lublin, PolandDepartment of Clinical Genetics, Medical University of Lublin, 20-080 Lublin, PolandDepartment of Obstetrics and Perinatology, Medical University of Lublin, 20-090 Lublin, PolandGestational diabetes mellitus (GDM) is a common metabolic disease that occurs during pregnancy, with the placenta playing an important role in its pathophysiology. Currently, the role of galectin-9 in the development of GDM is unknown. The aim of this study was to compare galectin-9 concentrations in healthy pregnant women and those with GDM. Galectin-9 levels were assessed in serum samples taken both just before and after delivery, as well as in urine samples collected in the postpartum period. Maternal body composition and hydration status were evaluated using the bioelectrical impedance analysis (BIA) method. There were no statistically significant differences in the concentration of galectin-9 in women with GDM compared to healthy pregnant women in their serum samples taken just before delivery, nor in their serum and urine samples collected in the early postpartum period. However, serum galectin-9 concentrations taken before delivery were positively correlated with BMI and parameters related to the amount of adipose tissue assessed in the early postpartum period. Additionally, there was a correlation between serum galectin-9 concentrations taken before and after delivery. Galectin-9 is unlikely to become a diagnostic marker for GDM. However, this subject requires further clinical research in larger groups.https://www.mdpi.com/2218-273X/13/4/697galectin-9gestational diabetes mellitusbioelectrical impedance analysispregnancy
spellingShingle Aleksandra Pełech
Monika Ruszała
Magdalena Niebrzydowska-Tatus
Katarzyna Bień
Żaneta Kimber-Trojnar
Monika Czuba
Małgorzata Świstowska
Bożena Leszczyńska-Gorzelak
Do Serum Galectin-9 Levels in Women with Gestational Diabetes and Healthy Ones Differ before or after Delivery? A Pilot Study
Biomolecules
galectin-9
gestational diabetes mellitus
bioelectrical impedance analysis
pregnancy
title Do Serum Galectin-9 Levels in Women with Gestational Diabetes and Healthy Ones Differ before or after Delivery? A Pilot Study
title_full Do Serum Galectin-9 Levels in Women with Gestational Diabetes and Healthy Ones Differ before or after Delivery? A Pilot Study
title_fullStr Do Serum Galectin-9 Levels in Women with Gestational Diabetes and Healthy Ones Differ before or after Delivery? A Pilot Study
title_full_unstemmed Do Serum Galectin-9 Levels in Women with Gestational Diabetes and Healthy Ones Differ before or after Delivery? A Pilot Study
title_short Do Serum Galectin-9 Levels in Women with Gestational Diabetes and Healthy Ones Differ before or after Delivery? A Pilot Study
title_sort do serum galectin 9 levels in women with gestational diabetes and healthy ones differ before or after delivery a pilot study
topic galectin-9
gestational diabetes mellitus
bioelectrical impedance analysis
pregnancy
url https://www.mdpi.com/2218-273X/13/4/697
work_keys_str_mv AT aleksandrapełech doserumgalectin9levelsinwomenwithgestationaldiabetesandhealthyonesdifferbeforeorafterdeliveryapilotstudy
AT monikaruszała doserumgalectin9levelsinwomenwithgestationaldiabetesandhealthyonesdifferbeforeorafterdeliveryapilotstudy
AT magdalenaniebrzydowskatatus doserumgalectin9levelsinwomenwithgestationaldiabetesandhealthyonesdifferbeforeorafterdeliveryapilotstudy
AT katarzynabien doserumgalectin9levelsinwomenwithgestationaldiabetesandhealthyonesdifferbeforeorafterdeliveryapilotstudy
AT zanetakimbertrojnar doserumgalectin9levelsinwomenwithgestationaldiabetesandhealthyonesdifferbeforeorafterdeliveryapilotstudy
AT monikaczuba doserumgalectin9levelsinwomenwithgestationaldiabetesandhealthyonesdifferbeforeorafterdeliveryapilotstudy
AT małgorzataswistowska doserumgalectin9levelsinwomenwithgestationaldiabetesandhealthyonesdifferbeforeorafterdeliveryapilotstudy
AT bozenaleszczynskagorzelak doserumgalectin9levelsinwomenwithgestationaldiabetesandhealthyonesdifferbeforeorafterdeliveryapilotstudy